{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:41:28Z","timestamp":1765960888948},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Aptalis Pharm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10620-015-3930-3","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T08:59:02Z","timestamp":1446109142000},"page":"861-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Hoda M.","family":"Malaty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhada","family":"Sansgiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avo","family":"Artinyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason K.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"3930_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4292\/wjgpt.v2.i2.9","volume":"14","author":"MH Madalinski","year":"2011","unstructured":"Madalinski MH. Identifying the best therapy for chronic anal fissure. World J Gastrointest Pharmacol Ther. 2011;14:9\u201316.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"3930_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1272820","volume":"14","author":"KN Zaghiyan","year":"2011","unstructured":"Zaghiyan KN, Fleshner P. Anal fissure. Clin Colon Rectal Surg. 2011;14:22\u201330.","journal-title":"Clin Colon Rectal Surg"},{"key":"3930_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10350-004-6556-7","volume":"46","author":"I Lindsey","year":"2003","unstructured":"Lindsey I, Jones OM, Cunningham C, George BD, Mortensen NJ. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum. 2003;46:361\u2013366.","journal-title":"Dis Colon Rectum"},{"key":"3930_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0974-2077.44160","volume":"1","author":"U Wollina","year":"2008","unstructured":"Wollina U. Pharmacological sphincterotomy for chronic anal fissures by botulinum toxin a. J Cutan Aesthet Surg. 2008;1:58\u201363.","journal-title":"J Cutan Aesthet Surg"},{"key":"3930_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1015-9584(08)60078-0","volume":"3","author":"B Medhi","year":"2008","unstructured":"Medhi B, Rao RS, Prakash A, Prakash O, Kaman L, Pandhi P. Advances in the pharmacotherapy of chronic anal fissure: an update. Asian J Surg. 2008;3:154\u2013163.","journal-title":"Asian J Surg"},{"key":"3930_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-14-129","volume":"14","author":"DM Mapel","year":"2014","unstructured":"Mapel DM, Schum M, Worley AV. The epidemiology and treatment of anal fissures in a population-based cohort. BMC Gastroenterol. 2014;14:1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"3930_CR7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/bjs.1800831006","volume":"83","author":"JN Lund","year":"1996","unstructured":"Lund JN, Scholefield JH. Etiology and treatment of anal fissure. Br J Surg. 1996;83:1335\u20131344.","journal-title":"Br J Surg"},{"key":"3930_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02603444","volume":"24","author":"DR Williams","year":"1981","unstructured":"Williams DR, Coller JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn\u2019s disease. Dis Colon Rectum. 1981;24:22\u201324.","journal-title":"Dis Colon Rectum"},{"key":"3930_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/bjs.1800750120","volume":"75","author":"JL Sweeney","year":"1988","unstructured":"Sweeney JL, Ritchie JK, Nicholls RJ. Anal fissure in Crohn\u2019s disease. Br J Surg. 1988;75:56\u201357.","journal-title":"Br J Surg"},{"key":"3930_CR10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/BF02048328","volume":"38","author":"PR Fleshner","year":"1995","unstructured":"Fleshner PR, Schoetz DJ Jr, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Anal fissure in Crohn\u2019s disease: a plea for aggressive management. Dis Colon Rectum. 1995;38:1137\u20131143.","journal-title":"Dis Colon Rectum"},{"key":"3930_CR11","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-014-3174-7","volume":"59","author":"JK Hou","year":"2014","unstructured":"Hou JK, Tan M, Stidham RW, et al. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn\u2019s disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014;59:2406\u20132410.","journal-title":"Dig Dis Sci"},{"key":"3930_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","volume":"50","author":"R Isene","year":"2015","unstructured":"Isene R, Bernklev T, H\u00f8ie O, et al. Extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50:300\u2013305.","journal-title":"Scand J Gastroenterol"},{"key":"3930_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110\u2013119.","journal-title":"Am J Gastroenterol"},{"key":"3930_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.MIB.0000436959.62286.f9","volume":"20","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213\u2013227.","journal-title":"Inflamm Bowel Dis"},{"key":"3930_CR15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ibd.20844","volume":"15","author":"CA Siegel","year":"2009","unstructured":"Siegel CA, MacDermott RP. Is chronic pain an extraintestinal manifestation of IBD? Inflamm Bowel Dis. 2009;15:769\u2013771.","journal-title":"Inflamm Bowel Dis"},{"key":"3930_CR16","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s10620-014-3160-0","volume":"59","author":"MA Sofia","year":"2014","unstructured":"Sofia MA, Rubin DT, Hou N, Pekow J. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci. 2014;59:2228\u20132235.","journal-title":"Dig Dis Sci"},{"key":"3930_CR17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ajg.2013.192","volume":"108","author":"KK Lin","year":"2013","unstructured":"Lin KK, Sewell JL. The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol. 2013;108:1824\u20131830.","journal-title":"Am J Gastroenterol"},{"key":"3930_CR18","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s10620-010-1442-8","volume":"55","author":"JL Sewell","year":"2010","unstructured":"Sewell JL, Inadomi JM, Yee HF Jr. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci. 2010;55:3479\u20133487.","journal-title":"Dig Dis Sci"},{"key":"3930_CR19","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/ajg.2010.202","volume":"105","author":"GC Nguyen","year":"2010","unstructured":"Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105:2202\u20132208.","journal-title":"Am J Gastroenterol"},{"key":"3930_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0148607109332907","volume":"33","author":"GC Nguyen","year":"2009","unstructured":"Nguyen GC, Munsell M, Brant SR, LaVeist TA. Racial and geographic disparities in the use of parenteral nutrition among inflammatory bowel disease inpatients diagnosed with malnutrition in the United States. J Parenter Enteral Nutr. 2009;33:563\u2013568.","journal-title":"J Parenter Enteral Nutr"},{"key":"3930_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ibd.20298","volume":"14","author":"MH Flasar","year":"2008","unstructured":"Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008;14:13\u201319.","journal-title":"Inflamm Bowel Dis"},{"key":"3930_CR22","first-page":"219","volume":"73","author":"P Sainio","year":"1984","unstructured":"Sainio P. Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynnaecol. 1984;73:219\u2013224.","journal-title":"Ann Chir Gynnaecol"},{"key":"3930_CR23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1297-9589(03)00127-9","volume":"31","author":"L Abramowitz","year":"2003","unstructured":"Abramowitz L, Batallan A. Epidemiology of anal lesions (fissure and thrombosed external hemorrhoid) during pregnancy and post-partum]. Gynecol Obstet Fertil. 2003;31:546\u2013549.","journal-title":"Gynecol Obstet Fertil"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3930-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3930-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3930-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:49:56Z","timestamp":1559245796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3930-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3930"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3930-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}